Acitrin-L Tablet 5 mg

Acitrin-L Tablet is a trusted antihistamine containing Levocetirizine Dihydrochloride 5 mg. Manufactured by ACI Limited, this non-sedating formula effectively treats allergic rhinitis and chronic hives. Priced at ৳3.01 per unit (10×10 strips: ৳301), it offers affordable allergy relief.

The active isomer of cetirizine binds twice as strongly to H1 receptors, ensuring prolonged action with once-daily dosing. Ideal for seasonal allergies and skin urticaria, it minimizes drowsiness while blocking histamine pathways. Clinical trials confirm its rapid onset within 1 hour and 24-hour efficacy.

Dosage guidelines vary by age:

• Adults: 5 mg daily
• 6-11 years: 2.5 mg (½ tablet)
• Infants (6 months+): 1.25 mg liquid formulation

Renal impairment requires dose adjustments based on creatinine clearance levels.

Common side effects include dry mouth (2.1%) and headache (1.3%), with rare rash occurrences. Pregnancy Category B classification suggests cautious use, while breastfeeding is discouraged due to milk secretion risks. No significant drug interactions reported with other medications.

Store below 30°C in dry, dark conditions. Available as immediate-release tablets and oral solutions. For alternatives, explore other non-sedating antihistamines or consult healthcare providers about Levocetirizine Dihydrochloride brands.

Adults & 12+ years: 5 mg once daily. 6-11 years: 2.5 mg, 6 months-5 years: 1.25 mg. Renal impairment requires dose reduction (CrCl 30-50: 2.5 mg every other day). Administer once daily with/without food. Treatment duration depends on symptom resolution.

Generally, levocetirizine is well tolerated. However, a few side effects like headache, dry mouth, fatigue and skin rash have been reported rarely.

Pregnancy Category B (US FDA). No fetal harm in animal studies, but human data limited. Not recommended during lactation – excreted in breast milk.

Use caution in epilepsy/seizure history. Maintain hydration. Monitor renal function regularly. Exercise caution while driving (though non-sedating).

No dose adjustment needed in elderly unless renal impairment exists. Hepatic impairment requires no modification. Strictly follow age-specific pediatric dosing.

No clinically relevant adverse events have been reported in case of overdose. However in the event of overdosage, symptomatic and supportive treatment is recommended.